329 related articles for article (PubMed ID: 28913816)
1. Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases.
Richey JM; Woolcott O
Curr Diab Rep; 2017 Sep; 17(10):99. PubMed ID: 28913816
[TBL] [Abstract][Full Text] [Related]
2. Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders.
Silvestri C; Di Marzo V
Expert Opin Investig Drugs; 2012 Sep; 21(9):1309-22. PubMed ID: 22780328
[TBL] [Abstract][Full Text] [Related]
3. The Peripheral Cannabinoid Receptor Type 1 (CB
O'Sullivan SE; Yates AS; Porter RK
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684760
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
Vemuri VK; Janero DR; Makriyannis A
Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
Després JP
Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
[TBL] [Abstract][Full Text] [Related]
7. The role of the endocannabinoid system in the control of energy homeostasis.
Osei-Hyiaman D; Harvey-White J; Bátkai S; Kunos G
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S33-8. PubMed ID: 16570103
[TBL] [Abstract][Full Text] [Related]
8. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
Pagotto U; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
[TBL] [Abstract][Full Text] [Related]
9. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
Simon V; Cota D
Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of targeting the peripheral endocannabinoid/CB
Tam J; Hinden L; Drori A; Udi S; Azar S; Baraghithy S
Eur J Intern Med; 2018 Mar; 49():23-29. PubMed ID: 29336868
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.
Janero DR; Makriyannis A
Expert Opin Emerg Drugs; 2009 Mar; 14(1):43-65. PubMed ID: 19249987
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.
Silvestri C; Di Marzo V
Cell Metab; 2013 Apr; 17(4):475-90. PubMed ID: 23562074
[TBL] [Abstract][Full Text] [Related]
13. The unfolding cannabinoid story on energy homeostasis: central or peripheral site of action?
Horvath TL
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S30-2. PubMed ID: 16570102
[TBL] [Abstract][Full Text] [Related]
14. Peripheral metabolic effects of endocannabinoids and cannabinoid receptor blockade.
Engeli S
Obes Facts; 2008; 1(1):8-15. PubMed ID: 20054157
[TBL] [Abstract][Full Text] [Related]
15. Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors.
Woods SC
Am J Med; 2007 Mar; 120(3 Suppl 1):S19-25. PubMed ID: 17320518
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs.
Murphy T; Le Foll B
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32512776
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid control of food intake and energy balance.
Di Marzo V; Matias I
Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
[TBL] [Abstract][Full Text] [Related]
18. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity.
Heyman E; Gamelin FX; Aucouturier J; Di Marzo V
Obes Rev; 2012 Dec; 13(12):1110-24. PubMed ID: 22943701
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents.
Sharma MK; Murumkar PR; Barmade MA; Giridhar R; Yadav MR
Expert Opin Ther Pat; 2015; 25(10):1093-116. PubMed ID: 26161824
[TBL] [Abstract][Full Text] [Related]
20. Energy balance regulation by endocannabinoids at central and peripheral levels.
Quarta C; Mazza R; Obici S; Pasquali R; Pagotto U
Trends Mol Med; 2011 Sep; 17(9):518-26. PubMed ID: 21816675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
